Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B3GNTL1 pseudogene 2 (B3GNTL1P2) is a human pseudogene located on chromosome 6. It is annotated as a non-coding genomic region related to the gene family encoding beta-1,3-N-acetylglucosaminyltransferase-like proteins. Pseudogenes such as B3GNTL1P2 arise from duplication or mutation of functional genes and do not produce functional protein. There is no evidence supporting any biological activity, role in diseases, or therapeutic relevance for B3GNTL1P2, and it is not considered a pharmacological or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 2 (B3GNTL1P2).